LOW DOSE CONTINUOUS THERAPY WITH DASATINIB SIGNIFICANTLY IMPACT ON SURVIVAL OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML) RESISTANT OR INTOLERANT TO IMATINIB. RESULTS FROM A REAL LIFE-BASED ITALIAN MULTICENTER RETROSPECTIVE STUDY ON 114 UNSELECTED PATIENTS

G. VISANI;M. BRECCIA;A. GOZZINI;G. SPECCHIA;E. MONTEFUSCO;E. MORRA;M. ANNUNZIATA;L. LUCIANO;A. CAMERA;F. CAVAZZINI;F. STAGNO;DI RAIMONDO, FRANCESCO;P. PREGNO;V. SANTINI;P. PICCALUGA;M. PACILLI;E. PUNGOLINO;E. USALA;E. ANGELUCCI;A. CUNEO;F. FERRARA;M. CRUGNOLA;G. BINOTTO;E. MAINO;R. LATAGLIATA;G. NICOLINI;S. BARULLI;F. LOSCOCCO;G. ALIMENA;A. ISIDORI

2010-01-01